These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 16979873

  • 1. Upregulated expression of kappa light chain by Epstein-Barr virus encoded latent membrane protein 1 in nasopharyngeal carcinoma cells via NF-kappaB and AP-1 pathways.
    Liu HD, Zheng H, Li M, Hu DS, Tang M, Cao Y.
    Cell Signal; 2007 Feb; 19(2):419-27. PubMed ID: 16979873
    [Abstract] [Full Text] [Related]

  • 2. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
    Ren Q, Sato H, Murono S, Furukawa M, Yoshizaki T.
    Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
    [Abstract] [Full Text] [Related]

  • 3. LMP1-augmented kappa intron enhancer activity contributes to upregulation expression of Ig kappa light chain via NF-kappaB and AP-1 pathways in nasopharyngeal carcinoma cells.
    Liu H, Zheng H, Duan Z, Hu D, Li M, Liu S, Li Z, Deng X, Wang Z, Tang M, Shi Y, Yi W, Cao Y.
    Mol Cancer; 2009 Oct 27; 8():92. PubMed ID: 19860880
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Heterodimer formation between c-Jun and Jun B proteins mediated by Epstein-Barr virus encoded latent membrane protein 1.
    Song X, Tao YG, Deng XY, Jin X, Tan YN, Tang M, Wu Q, Lee LM, Cao Y.
    Cell Signal; 2004 Oct 27; 16(10):1153-62. PubMed ID: 15240010
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cells in G2/M phase increased in human nasopharyngeal carcinoma cell line by EBV-LMP1 through activation of NF-kappaB and AP-1.
    Deng L, Yang J, Zhao XR, Deng XY, Zeng L, Gu HH, Tang M, Cao Y.
    Cell Res; 2003 Jun 27; 13(3):187-94. PubMed ID: 12862319
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The transmembrane domains of the EBV-encoded latent membrane protein 1 (LMP1) variant CAO regulate enhanced signalling activity.
    Blake SM, Eliopoulos AG, Dawson CW, Young LS.
    Virology; 2001 Apr 10; 282(2):278-87. PubMed ID: 11289810
    [Abstract] [Full Text] [Related]

  • 10. Epstein-Barr virus encoded latent membrane protein 1 induces TRAF1 expression to promote anti-apoptosis activity via NF-kappaB signaling pathway in nasopharyngeal carcinoma.
    Wang C, Ai M, Ren W, Xiao H, Li X, Tang F, Gu H, Yi W, Weng X, Deng X, Cao Y.
    Chin Med J (Engl); 2003 Jul 10; 116(7):1022-8. PubMed ID: 12890376
    [Abstract] [Full Text] [Related]

  • 11. Epstein-Barr virus-encoded LMP1 promotes cisplatin-induced caspase activation through JNK and NF-kappaB signaling pathways.
    Zhang X, Sanmun D, Hu L, Fadeel B, Ernberg I.
    Biochem Biophys Res Commun; 2007 Aug 17; 360(1):263-8. PubMed ID: 17586463
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Lack of cytotoxic property in a variant of Epstein-Barr virus latent membrane protein-1 isolated from nasopharyngeal carcinoma.
    Nitta T, Chiba A, Yamamoto N, Yamaoka S.
    Cell Signal; 2004 Sep 17; 16(9):1071-81. PubMed ID: 15212767
    [Abstract] [Full Text] [Related]

  • 14. Endogenous latent membrane protein 1 in Epstein-Barr virus-infected nasopharyngeal carcinoma cells attracts T lymphocytes through upregulation of multiple chemokines.
    Lai HC, Hsiao JR, Chen CW, Wu SY, Lee CH, Su IJ, Takada K, Chang Y.
    Virology; 2010 Sep 30; 405(2):464-73. PubMed ID: 20637487
    [Abstract] [Full Text] [Related]

  • 15. [EBV latent membrane protein 1 induces p53 expression via NF-kappa B in nasopharyngeal carcinoma].
    Liao W, Tang M, Yin L.
    Zhonghua Zhong Liu Za Zhi; 2001 May 30; 23(3):199-201. PubMed ID: 11783085
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Epstein-Barr virus latent membrane protein 1 modulates epidermal growth factor receptor promoter activity in a nuclear factor kappa B-dependent manner.
    Tao YG, Tan YN, Liu YP, Song X, Zeng L, Gu HH, Tang M, Li W, Yi W, Cao Y.
    Cell Signal; 2004 Jul 30; 16(7):781-90. PubMed ID: 15115657
    [Abstract] [Full Text] [Related]

  • 18. Transcriptional activation of NF-kappa B activity by Epstein-Barr virus (EBV) LMP1 as a selective therapeutic strategy for EBV-associated diseases.
    Wu CJ, Leu CY, Liu ST, Chow KP, Meng CL, Chang YS.
    Gene Ther; 1998 Jul 30; 5(7):905-12. PubMed ID: 9813661
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma.
    Thornburg NJ, Pathmanathan R, Raab-Traub N.
    Cancer Res; 2003 Dec 01; 63(23):8293-301. PubMed ID: 14678988
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.